Last updated on March 2018

Alzheimer's Disease Study


Brief description of study

Alzheimer's Disease Study

Detailed Study Description

This is a study for elderly patients (>= 55 years of age) who meet the NINCDS-ADRDA criteria for Alzheimer's Disease.

Patients screened at visit 1 who will meet all of the inclusion criteria, will be enrolled in the study and receive study therapy.

Qualified volunteers will receive compensation up to $4100 depending on their level of involvement.

Length of study: 6 months (including screening period)

Total number of outpatient visits: 11

Clinical Study Identifier: TX134072

Contact Investigators or Research Sites near you

Start Over

Study Coordinator

California Clinical Trials Medical Group, Inc.
Glendale, CA USA
  Connect »